Healthy individuals
Conditions
Interventions
None listed
Sponsors
Leverage Brain Inc. Clinical Trial Department
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subjects of both sexes above 20 years old- under 64 years old. 2) Subjects who competent to consent and give voluntary consent in writing with full understanding after receiving explanation of this study aim and contents.
Exclusion criteria
Exclusion criteria: 1) Subjects who have serious disorders on hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system, metabolic system. 2) Subjects who are under medication (especially subject who take warfarin) on a steady basis or history of medication for serious disorders. 3) Subjects who are under treatment for digestive system and Immune system disease (Autoimmune diseases, etc.) that effects on this study, or have previous history, or have history of operation on digestive system. 4) Subjects who regularly intake food with health-promoting benefits function or supplements that may possibly effect on the immunity. 5) Subjects work irregular hours on the night shift or irregular shift. 6) Subjects who smoke excessively and drink alcohol regularly. 7) Subjects with irregular lifestyle habit such as diet meal and sleep. 8) Subjects who had made blood donation within 4 weeks. 9) Subjects with history of sensitivity to the ingredients of test food. 10) Pregnant, lactating women or willing to be pregnancy during the study. 11) Subjects who participated in other monitoring study within 1 month prior to obtaining informed consent. 12) Any candidates considered to be unsuitable for enrollment in the opinion of the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Influenza vaccine antibody titer (Type A,Type B), and NK Cell activity | — |
Secondary
| Measure | Time frame |
|---|---|
| Triglycerides,totalcholesterol,HDL cholesterol,LDLcholesterol,The subject questionnaire regarding QOL | — |
Countries
Japan
Contacts
Public Contactshigeru imai
Leverage Brain Inc. Clinical Trial Department
Outcome results
None listed